PECAM1 and myocardial infarction: Pathological and immunohistological results show that apela can limit the area of myocardial infarction, reduce myocardial interstitial fibrosis and increase the proportion of CD31‐positive cells near the infracted area while significantly reducing the proportion of TUNEL‐positive cells.